Cargando…
Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study
INTRODUCTION: The level of expression of the immunoregulatory human leukocyte antigen-G (HLA-G) has been suggested to play a role in the immunopathogenesis of systemic lupus erythematosus (SLE). A 14 bp insertion/deletion (ins/del) polymorphism in the 3ˊuntranslated region of HLA-G gene may influenc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785136/ https://www.ncbi.nlm.nih.gov/pubmed/35082516 http://dx.doi.org/10.2147/IJGM.S344376 |
_version_ | 1784638899062046720 |
---|---|
author | Mohammed, Shrouk A Al Kady, Laila M Boghdadi, Ghada S Dawa, Ghada A Gerges, Marian A El Shafai, Maher A |
author_facet | Mohammed, Shrouk A Al Kady, Laila M Boghdadi, Ghada S Dawa, Ghada A Gerges, Marian A El Shafai, Maher A |
author_sort | Mohammed, Shrouk A |
collection | PubMed |
description | INTRODUCTION: The level of expression of the immunoregulatory human leukocyte antigen-G (HLA-G) has been suggested to play a role in the immunopathogenesis of systemic lupus erythematosus (SLE). A 14 bp insertion/deletion (ins/del) polymorphism in the 3ˊuntranslated region of HLA-G gene may influence the level of expression. The role of Toll-like receptor 9 (TLR9) in the pathogenesis of SLE has been highlighted. Data among Egyptian patients are quite limited. PURPOSE: To detect the association of HLA-G 14 bp ins/del gene polymorphism with the susceptibility to SLE and to correlate TLR9 serum level with disease activity among Egyptian patients. PATIENTS AND METHODS: A case-control study that included 102 SLE female patients and 102 healthy matched volunteers as controls was carried out. Disease activity in patients was determined using the modified Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). HLA-G 14 bp ins/del genotype was detected by polymerase chain reaction (PCR). TLR9 serum level was estimated using enzyme-linked immunosorbent assay (ELISA) technique. RESULTS: The ins/ins genotype was significantly increased among SLE patients compared to healthy subjects (58.8% vs 9.8%; odds ratio [OR] = 11.79, P < 0.001). The 14 bp ins allele was significantly more frequent in SLE patients than in healthy subjects (65.7% vs 27.9%, respectively) and significantly associated with an increased risk of SLE (OR 4.94, P < 0.001). The mean TLR9 serum level showed a significant increase in SLE patients compared to healthy subjects (397.04±137.86 vs 195.22±45.14 ng/L, p < 0.001) and was significantly associated with disease activity as well as to patients’ HLA-G genotypes (p < 0.001). CONCLUSION: Among Egyptian population, HLA-G 14 bp ins/ins homozygous genotype and ins allele may constitute a potential risk for SLE susceptibility, while TLR9 serum level is significantly associated with disease activity. |
format | Online Article Text |
id | pubmed-8785136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87851362022-01-25 Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study Mohammed, Shrouk A Al Kady, Laila M Boghdadi, Ghada S Dawa, Ghada A Gerges, Marian A El Shafai, Maher A Int J Gen Med Original Research INTRODUCTION: The level of expression of the immunoregulatory human leukocyte antigen-G (HLA-G) has been suggested to play a role in the immunopathogenesis of systemic lupus erythematosus (SLE). A 14 bp insertion/deletion (ins/del) polymorphism in the 3ˊuntranslated region of HLA-G gene may influence the level of expression. The role of Toll-like receptor 9 (TLR9) in the pathogenesis of SLE has been highlighted. Data among Egyptian patients are quite limited. PURPOSE: To detect the association of HLA-G 14 bp ins/del gene polymorphism with the susceptibility to SLE and to correlate TLR9 serum level with disease activity among Egyptian patients. PATIENTS AND METHODS: A case-control study that included 102 SLE female patients and 102 healthy matched volunteers as controls was carried out. Disease activity in patients was determined using the modified Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). HLA-G 14 bp ins/del genotype was detected by polymerase chain reaction (PCR). TLR9 serum level was estimated using enzyme-linked immunosorbent assay (ELISA) technique. RESULTS: The ins/ins genotype was significantly increased among SLE patients compared to healthy subjects (58.8% vs 9.8%; odds ratio [OR] = 11.79, P < 0.001). The 14 bp ins allele was significantly more frequent in SLE patients than in healthy subjects (65.7% vs 27.9%, respectively) and significantly associated with an increased risk of SLE (OR 4.94, P < 0.001). The mean TLR9 serum level showed a significant increase in SLE patients compared to healthy subjects (397.04±137.86 vs 195.22±45.14 ng/L, p < 0.001) and was significantly associated with disease activity as well as to patients’ HLA-G genotypes (p < 0.001). CONCLUSION: Among Egyptian population, HLA-G 14 bp ins/ins homozygous genotype and ins allele may constitute a potential risk for SLE susceptibility, while TLR9 serum level is significantly associated with disease activity. Dove 2022-01-18 /pmc/articles/PMC8785136/ /pubmed/35082516 http://dx.doi.org/10.2147/IJGM.S344376 Text en © 2022 Mohammed et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Mohammed, Shrouk A Al Kady, Laila M Boghdadi, Ghada S Dawa, Ghada A Gerges, Marian A El Shafai, Maher A Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study |
title | Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study |
title_full | Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study |
title_fullStr | Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study |
title_full_unstemmed | Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study |
title_short | Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study |
title_sort | immunogenetic relationship of hla-g 14 bp insertion/deletion polymorphism and toll-like receptor 9 with systemic lupus erythematosus in egyptian patients: a case-control study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785136/ https://www.ncbi.nlm.nih.gov/pubmed/35082516 http://dx.doi.org/10.2147/IJGM.S344376 |
work_keys_str_mv | AT mohammedshrouka immunogeneticrelationshipofhlag14bpinsertiondeletionpolymorphismandtolllikereceptor9withsystemiclupuserythematosusinegyptianpatientsacasecontrolstudy AT alkadylailam immunogeneticrelationshipofhlag14bpinsertiondeletionpolymorphismandtolllikereceptor9withsystemiclupuserythematosusinegyptianpatientsacasecontrolstudy AT boghdadighadas immunogeneticrelationshipofhlag14bpinsertiondeletionpolymorphismandtolllikereceptor9withsystemiclupuserythematosusinegyptianpatientsacasecontrolstudy AT dawaghadaa immunogeneticrelationshipofhlag14bpinsertiondeletionpolymorphismandtolllikereceptor9withsystemiclupuserythematosusinegyptianpatientsacasecontrolstudy AT gergesmariana immunogeneticrelationshipofhlag14bpinsertiondeletionpolymorphismandtolllikereceptor9withsystemiclupuserythematosusinegyptianpatientsacasecontrolstudy AT elshafaimahera immunogeneticrelationshipofhlag14bpinsertiondeletionpolymorphismandtolllikereceptor9withsystemiclupuserythematosusinegyptianpatientsacasecontrolstudy |